HEM Pharma Inc.
KOSDAQ-listed microbiome healthcare company using the PMAS gut-microbiome simulation platform and the PeachBiome028 probiotic strain.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2016 and listed on KOSDAQ in 2024, HEM Pharma is a microbiome-focused healthcare company. Using its PMAS gut-microbiome simulation technology, it operates personalized healthcare and LBP (live biotherapeutic product) discovery platform businesses, and holds the peach-derived probiotic strain PeachBiome028 (formally Lactiplantibacillus plantarum PeachBiome028, deposit no. KCCM13580P), combined with PDRN and EGF through its Multi Smart Formula formulation technology. PeachBiome028 has been verified to increase pro-collagen by 65%, improve skin regeneration about threefold, and inhibit harmful bacteria such as C. acnes by over 99.99%.
Products & technology
- PeachBiome028™peach-derived probiotic strain (skin regeneration, antibacterial)
- Multi Smart Formula™formulation technology combining PeachBiome028 with PDRN, EGF, collagen, and other ingredients
R&D and key agreements
Source: DART corporate disclosurePMAS(Personalized Pharmaceutical Meta-Analytical Screening) · LBP 후보물질·일반의약품·건강기능식품·파이토케미컬과 개인 마이크로바이옴 상호작용 연구 · 플랫폼 운영중 · Proprietary culture technology simulating fecal microbiome activity to study interactions with LBP candidates, drugs, supplements, and phytochemicals
Companies in the same categoryHealthcare Infrastructure
Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.
Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.
Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.
CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.
Founded in 1992 and listed on KOSPI in 2006, COSMAX BTI is the COSMAX Group holding company overseeing health food and cosmetics affiliates.
Founded in 2000 and listed on KOSDAQ in 2018, Icure Pharmaceutical develops TDDS drug patches and cosmetics OEM/ODM.
Carelabs, founded in 2012 and KOSDAQ-listed in 2018, operates mobile healthcare and beauty care platforms.
Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.
Founded in 1998 and listed on KOSDAQ in 2021, S&D is a functional food ingredient company.
Founded in 1991 and listed on KOSDAQ in 2002, CosLeaguer Global distributes botulinum toxin and fillers and manufactures cosmetics.
Develops water-solubilized curcumin complexes for enhanced bioavailability using its WIN-T technology.
Founded and listed on KOSDAQ in 2014, GL Pharm Tech is an improved-new-drug pharmaceutical R&D company.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition